CDK5 is commonly overexpressed and significantly correlated with several poor prognostic parameters of breast cancer. Its overexpression also exhibited a potential synergy in promoting TGF-β1–induced EMT (epithelial-mesenchymal transition) [39]. Here, CDK5 is linked to breast cancer.